TP53 Mutations in myelodysplastic syndrome

Leukemia and Lymphoma

Volumn 23, Issue 5-6, 1996, Pages 417-422

  Misawa, Shinichi ^a   Horiike, Shigeo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Karyotype; Molecular epidemiology; Myelodysplastic syndrome; NRAS gene; p53 gene

Indexed keywords

CHROMOSOME 17; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME LOSS; GENE MUTATION; KARYOTYPE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0030463176     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054848     Document Type: Review

References (51)

1. Zambetti, G. P. and Levine, A. J. (1993) A comparison of the biological activities of wild-type and mutant p53. FASEB J., 7, 855-865.
2. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C. C. (1991) p53 mutations in human cancers Science, 253, 49-53.
3. de Fromentel, C. C. and Soussi, T. (1992) TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromo & Cancer, 4, 1-15.
4. Greenblatt, M. S., Bennett, W. P., Hollstein, M. and Harris, C. C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathosenesis. Cancer Res , 54, 4855-4878.
5. Fenaux, P., d'Hooghe, M. C., Jonveaux, P., Lai, J. L., Bauters, F., Loucheux, M. H. and Kerckaert, J. P. (1990) Rearrangement and expression of the p53 gene in myelodysplastic syndrome and acute myeloid leukemia. Nouv. Rev. Fr. Hematol., 32, 341-344.
6. Ahuja, H., Bar-Eli, M., Advani, S. H., Benchimol, S. and Cline, M. J. (1989) Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc. Natl. Acad. Sci. USA, 86, 6783-6787.
7. Kelman, Z., Prokocimer, M., Peller, S., Kahn, Y., Rechavi, G., Manor, Y., Cohen, A. and Rotter, V. (1989) Rearrangements in the p53 gene in Philadelphia chromosome positive chrome myelogenous leukemia. Blood, 74, 2318-2324.
8. Ahuja, H., Bar-Eli, M., Arlin, Z., Advani, S., Allen, S. L. Goldman, J., Snyder, D., Foti, A. and Cline, M. J. (1991) The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. J. Clin. Invest. 87, 2042-2047
9. Jonveaux, P., Fenaux, P., Quiquandon, I., Pignon, J. M., Lai, J. L., Loucheux-Lefebvre, M. H., Goossens, M., Bauters, F. and Berger, R. (1991) Mutations in the p53 gene in myelodysplastic syndromes. Oncogene, 6, 2243-2247.
10. Ludwig, L., Schulz, A. S., Janssen, W. G., Gruenewald, K. and Bartram, C. R. (1992) P53 mutations in myelodysplastic syndromes. Leukemia, 6, 1302-1304.
11. Mori, N., Wada, M., Yokota, J., Terada, M , Okada, M., Teramura, M., Masuda, M , Hoshino, S., Motoji, T., Oshimi, K and Mizoguchi, H (1992) Mutations of the p53 tumor suppressor gene in hematologic neoplasms. Brit J. Haematol., 81, 235-240.
12. Tsushita, K , Hotta, T., Ichikawa, A. and Saito, H. (1992) Mutation of p53 gene does not play a critical role in myelodysplastic syndrome and its transformation to acute leukemia. Br. J. Haematol., 82, 456-457.
13. Sugimoto, K., Hirano, N., Toyoshima, H., Chiba, S., Mano, H., Takaku, F., Yazaki, Y. and Hirai, H. (1993) Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. Blood, 81, 3022-3026.
14. Wattel, E., Preudhomme, C., Hecquet, B , Vanrumbeke, M., Quesnel, B., Dervite, I., Morel, P. and Fenaux, P (1994) P53 mutations are associated with resistance to chemotherapy and short survival m hematologic malignancies. Blood, 84, 3148-3157.
15. Kaneko, H., Misawa, S., Horiike, S., Nakai, H and Kashima, K., (1995) TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities. Blood, 85, 2189-2193.
16. Gaidano, G., Ballerini, P., Gong, J. Z., Inghirami, G , Neri, A., Newcomb, E. W., Magrath, I. T., Knowles, D M. and Dalla-Favera, R. (1991) p53 mutations m human lymphoid malignancies: association with Burkit lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA, 88, 5413-5417.
17. Fenaux, P., Jonveaux, P., Quiquandon, I., Preudhomme, C., Lai, J. L., Vanrumbeke, M., Loucheux-Lefebvre, M. H., Bauters, F., Berger, R. and Kerckaert, J. P (1992) Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases. Leukemia, 6, 42-46.
18. Ichikawa, A., Hotta, T., Takagi, N., Tsushita, K , Kinoshna, T., Nagai, H., Murakami, Y., Hayashi, K. and Saito, H. (1992) Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. Blood, 79, 2701-2707.
19. Sander, C. A., Yano, T., Clark, H. M. Harris, C., Longo, D L., Jaffe, E. S. and Raffeld, M. (1993) P53 mutation is associated with progression in follicular lymphomas Blood, 82, 1994-2004.
20. Wada, M , Bartram, C. R., Nakamura, H., Hachiya, M , Chen, D , Borenstein, J , Miller, C. W , Ludwig, L., Hansen-Hagge, T. E., Ludwig, W. D., Reiter, A., Mizoguchi, H. and Koeffler, H. P. (1993) Analysis of p53 mutations in a large series of lymphoid hematologie malignancies of childhood. Blood, 82, 3163-3169.
21. Nakai, H., Misawa, S., Toguchida, J , Yandell, D. W. and Ishizaki, K. (1992) Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p. Cancer Res., 52, 6588-6593.
22. Nakai, H. and Misawa, S (1995) Chromosome 17 abnormalities and inactivation of the p53 gene in chronic myeloid leukemia and their prognostic significance. Leukemia and Lymphoma, 19, 213-221.
23. Fenaux, P., Jonveaux, P., Quiquandon, L. Lai, J. L., Pignon, J. M., Loucheux-Lefebvre, M. H., Bauters, F., Berger, R. and Kerckaert, J. P. (1991) P53 gene mutations in acute myeloid leukemia with 17p monosomy. Blood, 78, 1652-1657.
24. Neri, A., Baldini, L., Trecca, D., Cro, L., Polli, E. and Maiolo, A. T. (1993) P53 gene mutations in multiple myeloma are associated with advanced forms of malignancy. Blood, 81, 128-135.
25. Sugimoto, K., Toyoshima, H., Sakai, R., Miyagawa, K., Hagiwara, K., Hirai, H., Ishikawa, F. and Takaku, F. (1991) Mutations of the p53 gene in lymphoid leukemia. Blood, 77, 1153-1156.
26. Horiike, S., Tamwaki, M., Misawa, S and Abe, T. (1988) Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplaslic syndrome and predictive value for prognosis. Cancer. 62, 1129-1138.
27. Lai, J. L., Preudhomme. C., Zandecki, M., Flactif, M., Vanrumbeke, M., Lepelley, P., Wattel, E. and Fenaux, P. (1995) Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion, an entity characterized by specific dysgranulopoiesis and a high incidence of p53 mutations. Leukemia, 9, 370-381.
28. Nakai, H., Kaneko, H., Nakao, M., Horiike, S. and Misawa, S. (1994) Is inactivation of the p53 gene a common event in leukemias and myelodysplastic syndrome with rnonosomy 17p? Leukemia, 8, 1247-1248.
29. Lane, D. P. (1992) p53, guardian of the genome. Nature, 358, 15-16.
30. Horiike, S., Misawa, S., Nakai, H., Kaneko, H., Yokota, S., Tamwaki, M., Yamane, Y , Inazawa, J., Abe, T. and Kashima, K. (1994) N-ras mutation and karyotypic evolution are closely associated with leukemic transformation in myelodysplastic syndrome. Leukemia, 8, 1331-1336.
31. Parada, L. F , Land, H., Weinberg, R A., Wolf, D. and Rotter, V. (1984) Cooperation between gene encoding p53 tumor antigen and ras in cellular transformation. Nature, 312, 649-651.
32. Pailegata, N. S., Sessa, F., Renaut, B., Bonato, M., Leone, B. E., Salcia, E and Ranzani, G. N. (1994) K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res., 54, 1556-1560.
33. Sessa. F., Pellegata, N S., Bonato, M., Capella, C., Solcia, E., Kloppel, G. and Ranzani, G. N. (1993) Mutation of p53 and K-ras in intraductal papillary tumor are related to grade of epithelial dysplasia. Digestion, 54, 308-309.
34. Lehman, T. A., Bennett, W. P., Metcalf, R. A., Welsh, J A., Eckeer, J., Modali, R. V , Ullrich, S., Romano, J. W., Appella, E., Testa, J. R., Gerwin, B. I. and Harris, C. C. (1991) p53 mutations, ras mutations and p53-heat-shock 70 protein completes in human lung carcinoma cell lines. Cancer Res., 51, 4090-4096.
35. Mitsudomi, T., Steinberg, S. M., Nau, M M., Carbone, D., D'Amico, D., Bodner, S., Oie, H. K., Linnoila, R. I., Mullshine, J. L., Minna, J. D. and Gazdar, A F. (1992) P53 mutations in non-small-cell-lung cancer cell lines and their correlation with the presence of ras mutations and clinical features Oncogene, 7, 171-180.
36. Wolf, D. and Rotter, V. (1985) Major deletions in the gene coding the p53 tumor antigen cause lack of p53 expression in HL60 cells. Proc Natl Acad. Sci. USA, 82, 790-794.
37. Bos, J., Verlaan-de Vries, M., Jansen, A., Veeneman, G., van Boon, J and Vander Eb A. (1984) Three different mutations in codon 61 of the human N-ras gene detected by synthetic oligonucleotide hybridization. Nucleic Acids Res., 12, 9155-9162.
38. Gaidano, G., Guerrasio, A., Serra, A., Carozzi, F., Cambrin, G R., Petroni, D., Saglio, G (1993) Mutations in the p53 and ras family genes are associated with tumor progression of BCR/ABL negative chronic myeloproliferative disorders. Leukemia, 7, 946-953.
39. Buhler-Leclerc, M., Gratwohl, A. and Senn, H. P. (1993) Occurrence of point mutations in p53 gene is not increased in patients with acute myeloid leukaemia carring an activating N-ras mutation. Brit. J. Haematol., 84, 443-450.
40. Hollstein, M. C., Pert, L., Mandard, A. M., Welsh, J. A., Montesano, R., Metcalf, R. A., Bak, M. and Harris, C. C. (1991) Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res., 51, 4102-4103.
41. Bashey, A., Gill, R., Levi, S., Farr, C. J., Clutterbuck, R., Miller, J. L., Pragnell, I. B. and Marshall, C. J. (1992) Mutational activation of the N-ras oncogene assessed in primary clonogenic culture of acute myeloid leukemia (AML): implications for the role of N-ras mutation in AML pathogenesis. Blood, 79, 981-989.
42. Van Kamp, H., de Pijper, C., de Vries, M. V., Bos, J. L., Leeksma, C H. W., Krekhofs, H., Willemze, R., Fibbe, W. E. and Landegent, J. E. (1992) Longitudinal analysis of point mutations of the N-ras proto-oncogene in patients with myelodysplasia using archived blood smears. Blood, 79, 1266-1270.
43. Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J., Wan, N. J. and Harris. C. C. (1991) p53 gene mutational hotspot in human hepatocellular carcinomas from Qidong, China. Nature, 350, 427-428.
44. Slingerland, J. M., Minden, M. D. and Benchimol, S. (1991) Mutation of the p53 gene in human acute myelogenous leukemia. Blood, 77, 1500-1507.
45. Cesarman, E., Chadburn, A., Inghirami, G., Gaidano, G. and Knowles, D. M. (1992) Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Blood, 80, 3205-3216.
46. Sakashita, A., Hattori, T., Miller, C. W., Suzushima, H., Asou, N., Takatsuki, K. and Koeffler, H. P. (1992) Mutations of the p53 gene in adult T-cell leukemia. Blood, 79, 477-480.
47. Bhatia, K. G., Gutierrez, M. L. Huppi, K., Siwarski, D. and Magrath, I. T. (1992) The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors. Cancer Res., 52, 4273-4276.
48. Neubauer, A., He, M., Schmidt, C. A., Huhn, D. and Liu, E T. (1993) Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques. Leukemia, 7, 593-600.
49. Gaidano, G., Serra, A., Guerrasio, A., Rege-Cambrin, G., Mazza, U. and Saglio, G. (1994) Genetic analysis of p53 and RB1 tumor-suppressor genes in biast crisis of chronic myeloid leukemia. Ann. Hematol., 68, 3-7.
50. Le Beau, M. M., Albain, K S., Larson, R. A., Vardiman, J. W., Davis, E. M., Blough, R. B , Golomb, H. M. and Rowley, J. D. (1986) Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes No. 5 and 7. J. Clin. Oncol., 4, 325-345.
51. Pedersen-Bjergaard, J , Philip, P., Larsen, S. O., Andersson, M., Daugaard, G , Ersboell, J., Hansen, S. W., Hou-Jensen, K., Nielsen, D., Sigsgaard, T C., Specht, L. and Oesterlind, K. (1993) Therapy-related myelodysplasia and acute myeloid leukemia, cytogenetic characteristics of 115 concecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen Series. Leukemia, 7, 1975-1986.